Paul Aisen

Paul Stephen Aisen is an American physician and Alzheimer's disease researcher who is the founding director of the University of Southern California Alzheimer's Therapeutic Research Institute (ATRI). Since the 1990s, Aisen has been a leading figure in Alzheimer's disease research, developing novel methodologies and directing large-scale clinical trials to develop groundbreaking medications. Research that he co-authored led to the U.S. Food and Drug Administration's approval of some of the first Alzheimer's disease-modifying drugs. Aisen serves as the Epstein Alzheimer's disease director's chair and a professor of neurology at the Keck School of Medicine of USC. Provided by Wikipedia
Showing 1 - 1 results of 1 for search 'Paul Aisen', query time: 0.01s Refine Results
  1. 1
    Heterogeneous clinical phenotypes of sporadic early-onset Alzheimer’s disease: a neuropsychological data-driven approach

    Heterogeneous clinical phenotypes of sporadic early-onset Alzheimer’s disease: a neuropsychological data-driven approach by Deepti Putcha, Yuta Katsumi, Alexandra Touroutoglou, Ani Eloyan, Alexander Taurone, Maryanne Thangarajah, Paul Aisen, Jeffrey L. Dage, Tatiana Foroud, Clifford R. Jack, Joel H. Kramer, Kelly N. H. Nudelman, Rema Raman, Prashanthi Vemuri, Alireza Atri, Gregory S. Day, Ranjan Duara, Neill R. Graff-Radford, Ian M. Grant, Lawrence S. Honig, Erik C. B. Johnson, David T. Jones, Joseph C. Masdeu, Mario F. Mendez, Erik Musiek, Chiadi U. Onyike, Meghan Riddle, Emily Rogalski, Stephen Salloway, Sharon Sha, R. Scott Turner, Thomas S. Wingo, David A. Wolk, Kyle Womack, Maria C. Carrillo, Gil D. Rabinovici, Bradford C. Dickerson, Liana G. Apostolova, Dustin B. Hammers, the LEADS Consortium

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: